Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Tyler Turchan

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Annals of Palliative Medicine|January 14, 2021
The role of immunotherapy in combination with oligometastasis-directed therapy: a narrative reviewWilliam Tyler Turchan, Steven J Chmura
Seminars in Radiation Oncology|August 30, 2021
Chemoradiation for Anal Cancer: Clinical Outcomes and Strategies to Optimize the Therapeutic Ratio According to HPV StatusWilliam Tyler Turchan, Stanley L Liauw
International Journal of Radiation Oncology, Biology, Physics|October 16, 2022
Beyond the Visible Spectrum: Considering the Oligometastatic Hypothesis in the Light of a New EraWilliam Tyler Turchan, Sean P Pitroda, Ralph R Weichselbaum
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2021
Radiotherapy and Immunotherapy Combinations in the Treatment of Patients with Metastatic Disease: Current Status and Future FocusWilliam Tyler Turchan, Sean P Pitroda, Ralph R Weichselbaum
International Journal of Molecular Sciences|September 10, 2021
Treatment of Cancer with Radio-Immunotherapy: What We Currently Know and What the Future May HoldWilliam Tyler Turchan, Sean P Pitroda, Ralph R Weichselbaum
Neoplasia (New York, N.Y.)|March 18, 2022
Combined radio-immunotherapy: An opportunity to increase the therapeutic ratio of oligometastasis-directed radiotherapyWilliam Tyler Turchan, Sean P Pitroda, Ralph R Weichselbaum
Head & Neck|April 8, 2022
Decreased overall survival in patients with locally advanced head and neck cancer receiving definitive radiotherapy and concurrent cetuximab: National Cancer Database analysisMark C Korpics, William Tyler Turchan, Matthew Koshy, et al.
Urologic Oncology|January 19, 2020
PI-RADS score is associated with biochemical control and distant metastasis in men with intermediate-risk and high-risk prostate cancer treated with radiation therapyWilliam Tyler Turchan, Greg Kauffmann, Pritesh Patel, et al.
JNCI Cancer Spectrum|January 7, 2021
Prostate Cancer Radiotherapy: Increased Biochemical Control and Late Toxicity in Men With Medication AllergiesWilliam Tyler Turchan, Stanley I Gutiontov, Michael T Spiotto, et al.
Head & Neck|May 7, 2021
Impact of anatomic site of distant metastasis on survival in salivary gland cancersWilliam Tyler Turchan, Mark C Korpics, Michael Rooney, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Annals of Palliative Medicine|January 14, 2021
The role of immunotherapy in combination with oligometastasis-directed therapy: a narrative reviewWilliam Tyler Turchan, Steven J Chmura
Seminars in Radiation Oncology|August 30, 2021
Chemoradiation for Anal Cancer: Clinical Outcomes and Strategies to Optimize the Therapeutic Ratio According to HPV StatusWilliam Tyler Turchan, Stanley L Liauw
International Journal of Radiation Oncology, Biology, Physics|October 16, 2022
Beyond the Visible Spectrum: Considering the Oligometastatic Hypothesis in the Light of a New EraWilliam Tyler Turchan, Sean P Pitroda, Ralph R Weichselbaum
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2021
Radiotherapy and Immunotherapy Combinations in the Treatment of Patients with Metastatic Disease: Current Status and Future FocusWilliam Tyler Turchan, Sean P Pitroda, Ralph R Weichselbaum
International Journal of Molecular Sciences|September 10, 2021
Treatment of Cancer with Radio-Immunotherapy: What We Currently Know and What the Future May HoldWilliam Tyler Turchan, Sean P Pitroda, Ralph R Weichselbaum
Neoplasia (New York, N.Y.)|March 18, 2022
Combined radio-immunotherapy: An opportunity to increase the therapeutic ratio of oligometastasis-directed radiotherapyWilliam Tyler Turchan, Sean P Pitroda, Ralph R Weichselbaum
Head & Neck|April 8, 2022
Decreased overall survival in patients with locally advanced head and neck cancer receiving definitive radiotherapy and concurrent cetuximab: National Cancer Database analysisMark C Korpics, William Tyler Turchan, Matthew Koshy, et al.
Urologic Oncology|January 19, 2020
PI-RADS score is associated with biochemical control and distant metastasis in men with intermediate-risk and high-risk prostate cancer treated with radiation therapyWilliam Tyler Turchan, Greg Kauffmann, Pritesh Patel, et al.
JNCI Cancer Spectrum|January 7, 2021
Prostate Cancer Radiotherapy: Increased Biochemical Control and Late Toxicity in Men With Medication AllergiesWilliam Tyler Turchan, Stanley I Gutiontov, Michael T Spiotto, et al.
Head & Neck|May 7, 2021
Impact of anatomic site of distant metastasis on survival in salivary gland cancersWilliam Tyler Turchan, Mark C Korpics, Michael Rooney, et al.
Pageof 2